Toxins News and Research

RSS

New findings raise hope for novel class of drugs to treat lupus

New findings by a biomedical engineer and his team at the University of Houston raise hope for a new class of drugs to treat lupus that may not include the long list of adverse risks and side effects often associated with current treatments for this disease.

25 Sep 2014

UW-Madison and Morgridge researchers are creating tissue chip technology to screen neural toxins

A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that may harm human development.

24 Sep 2014

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Elusys Therapeutics, Inc., a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed three phase 3 healthy adult volunteer safety studies of obiltoxaximab (ETI-204).

23 Sep 2014

Gilead to boost price of new hepatitis c drug

Gilead Sciences says its next generation drug to combat hepatitis C, slated to launch next month, will be more expensive than $1,000-a-pill Sovaldi, in part because the new treatment will be shorter and simpler. Gilead also struck a deal with Indian generic drugmakers to sell lower-cost versions of Sovaldi in poor countries.

From Baxter International Inc. 16 Sep 2014

First synthetic membranes made without solvents on silicon surfaces

Artificial membranes mimicking those found in living organisms have many potential applications ranging from detecting bacterial contaminants in food to toxic pollution in the environment to dangerous diseases in people.

10 Sep 2014

Center Director of Omni Eye Surgery describes promising option for managing lid disease

Omni Eye Services, a leading provider of ophthalmologic services at five locations in New York and New Jersey, today announced that Dr. Katherine M Mastrota, Center Director of Omni Eye Surgery in New York City, has written a treatment update for Contact Lenses Today describing a promising "new option for managing lid disease."

9 Sep 2014

Cholera against cholera: an interview with Dr Bruce Turnbull, University of Leeds

Cholera bacteria, and other types of bacteria that cause diarrheal diseases, infect your intestines where they release AB5 protein toxins – that is they have a single toxic A-subunit that is linked to a pentamer of B-subunits that act as the delivery vehicle to transport the A-subunit into the cells.

8 Sep 2014

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

Fractyl Laboratories Inc. today announced positive clinical data for the first procedural therapy to directly treat the underlying digestive causes of insulin resistance in patients with uncontrolled type 2 diabetes.

4 Sep 2014

New research suggests that tomato-rich diet can lower prostate cancer risk

Men who eat over 10 portions a week of tomatoes have an 18 per cent lower risk of developing prostate cancer, new research suggests.

28 Aug 2014

Female rats whose great grandparents exposed to toxins become more vulnerable to stress

Scientists have known that toxic effects of substances known as endocrine disrupting chemicals (EDCs), found in both natural and human-made materials, can pass from one generation to the next, but new research shows that females with ancestral exposure to EDC may show especially adverse reactions to stress.

26 Aug 2014

Greater Toronto Area continues to violate Canada-wide standards for ozone air pollution

A new study shows that while the Greater Toronto Area has significantly reduced some of the toxins that contribute to smog, the city continues to violate the Canada-wide standards for ozone air pollution.

22 Aug 2014

Some mothers-to-be opt out of getting flu vaccine despite recommendations from physicians

Both mother and fetus are at increased risk for complications of flu infection during pregnancy. And prenatal care providers say they're advising women to get the flu vaccine, in line with recommendations from various organizations. But many pregnant women don't understand the importance of this advice-and don't get the vaccine.

19 Aug 2014

Microbes influence human eating behavior, dietary choices

It sounds like science fiction, but it seems that bacteria within us — which outnumber our own cells about 100-fold — may very well be affecting both our cravings and moods to get us to eat what they want, and often are driving us toward obesity.

17 Aug 2014

Modified C. novyi-NT bacterium produces precisely targeted anti-tumor response

A modified version of the Clostridium novyi (C. novyi-NT) bacterium can produce a strong and precisely targeted anti-tumor response in rats, dogs and now humans, according to a new report from Johns Hopkins Kimmel Cancer Center researchers.

14 Aug 2014

Researchers reveal importance of highly specialised immune cells in killing melanoma cells

Melbourne researchers have revealed the critical importance of highly specialised immune cells, called natural killer cells, in killing melanoma cells that have spread to the lungs.

14 Aug 2014

Injections of anaerobic bacteria can shrink tumors in rats, dogs and human

Deep within most tumors lie areas that remain untouched by chemotherapy and radiation. These troublesome spots lack the blood and oxygen needed for traditional therapies to work, but provide the perfect target for a new cancer treatment using bacteria that thrive in oxygen-poor conditions.

14 Aug 2014

Partial nephrectomy offers near equivalent lengths of cancer control compared to radical nephrectomy

Needle-guided tumor destruction procedures offer near equivalent lengths of local cancer control compared to surgery for patients with small kidney cancer tumors, according to the results of a large study published in the journal European Urology.

13 Aug 2014

$Research: Oxidative stress predicts hip fracture in postmenopausal women$

Research: Oxidative stress predicts hip fracture in postmenopausal women

Oxidative stress is a significant predictor for hip fracture in postmenopausal women, according to new research led by University of Cincinnati (UC) epidemiologists.

13 Aug 2014

Bee, snake, scorpion venom could form basis of new generation of cancer-fighting drugs

Bee, snake or scorpion venom could form the basis of a new generation of cancer-fighting drugs, scientists will report here today.

12 Aug 2014

Oncothyreon acquires Alpine Biosciences to enable targeted delivery of multiple therapeutic agents

Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.

12 Aug 2014

Toxins News and Research

New findings raise hope for novel class of drugs to treat lupus

UW-Madison and Morgridge researchers are creating tissue chip technology to screen neural toxins

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Gilead to boost price of new hepatitis c drug

First synthetic membranes made without solvents on silicon surfaces

Center Director of Omni Eye Surgery describes promising option for managing lid disease

Cholera against cholera: an interview with Dr Bruce Turnbull, University of Leeds

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

New research suggests that tomato-rich diet can lower prostate cancer risk

Female rats whose great grandparents exposed to toxins become more vulnerable to stress

Greater Toronto Area continues to violate Canada-wide standards for ozone air pollution

Some mothers-to-be opt out of getting flu vaccine despite recommendations from physicians

Microbes influence human eating behavior, dietary choices

Modified C. novyi-NT bacterium produces precisely targeted anti-tumor response

Researchers reveal importance of highly specialised immune cells in killing melanoma cells

Injections of anaerobic bacteria can shrink tumors in rats, dogs and human

Partial nephrectomy offers near equivalent lengths of cancer control compared to radical nephrectomy

Research: Oxidative stress predicts hip fracture in postmenopausal women

Bee, snake, scorpion venom could form basis of new generation of cancer-fighting drugs

Oncothyreon acquires Alpine Biosciences to enable targeted delivery of multiple therapeutic agents

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News